A blood cancer can be a devastating diagnosis, but thanks to world-leading expertise at @OSUCCC_James, we’re working to be able to deliver the best treatment to every individual patient, every time. In this new “Pass the Mic,” Dr. Ann-Kathrin Eisfeld talks about how she and her colleagues are staying on the cutting edge in researching and treating rare leukemias and other blood disorders – and ultimately creating hope for patients and their loved ones.

Excited to share @RibackLab’s first paper in @CellCellPress. Together with @Goodell_Lab, we show that diverse leukemia mutations converge on a biophysically indistinguishable nuclear condensate—the C-body. Huge thanks to @Gandhar_Datar, @sciencyelmira, and co-authors!